[go: up one dir, main page]

FI20075483A0 - Uusi peptidi - Google Patents

Uusi peptidi

Info

Publication number
FI20075483A0
FI20075483A0 FI20075483A FI20075483A FI20075483A0 FI 20075483 A0 FI20075483 A0 FI 20075483A0 FI 20075483 A FI20075483 A FI 20075483A FI 20075483 A FI20075483 A FI 20075483A FI 20075483 A0 FI20075483 A0 FI 20075483A0
Authority
FI
Finland
Prior art keywords
new peptide
peptide
new
Prior art date
Application number
FI20075483A
Other languages
English (en)
Swedish (sv)
Inventor
Emma Pirilae
Juho Suojanen
Timo Sorsa
Tuula Salo
Erkki Koivunen
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Priority to FI20075483A priority Critical patent/FI20075483A0/fi
Publication of FI20075483A0 publication Critical patent/FI20075483A0/fi
Priority to PCT/FI2008/050386 priority patent/WO2009000971A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI20075483A 2007-06-25 2007-06-25 Uusi peptidi FI20075483A0 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20075483A FI20075483A0 (fi) 2007-06-25 2007-06-25 Uusi peptidi
PCT/FI2008/050386 WO2009000971A2 (en) 2007-06-25 2008-06-24 A novel peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075483A FI20075483A0 (fi) 2007-06-25 2007-06-25 Uusi peptidi

Publications (1)

Publication Number Publication Date
FI20075483A0 true FI20075483A0 (fi) 2007-06-25

Family

ID=38212454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075483A FI20075483A0 (fi) 2007-06-25 2007-06-25 Uusi peptidi

Country Status (2)

Country Link
FI (1) FI20075483A0 (fi)
WO (1) WO2009000971A2 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2697196A1 (en) 2011-04-13 2014-02-19 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
WO2015073538A2 (en) * 2013-11-12 2015-05-21 Echogen, Inc. Interaction with metalloenzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010795A2 (en) * 1996-09-10 1998-03-19 The Burnham Institute Tumor homing molecules, conjugates derived therefrom, and methods of using same
US6180084B1 (en) * 1998-08-25 2001-01-30 The Burnham Institute NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same

Also Published As

Publication number Publication date
WO2009000971A2 (en) 2008-12-31
WO2009000971A3 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
CY2022032I1 (el) Συνθετικα πεπτιδικα αμιδια
BRPI0911743A2 (pt) "peptídeo"
EP2118122A4 (en) NOVEL ANTIMICROBIAL PEPTIDES
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
EP2215246A4 (en) PROTEIN SCAFFOLDS
BRPI0814587A2 (pt) Peptídeos antibióticos
DK3118220T3 (da) Protein
HRP20151120T1 (xx) Polipeptid ace2
DK2046826T3 (da) Exendin-fusionsproteiner
DK2035447T3 (da) Polypeptid
EP2139906A4 (en) aminophosphine
DK2035451T3 (da) Insulinoptrop peptidsyntese
BRPI0814971A2 (pt) Proteína
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
EP2010561A4 (en) ANTIMICROBIAL PEPTIDES
BRPI0814763A2 (pt) Peptídeos imunomoduladores
HRP20150195T1 (xx) Antibakterijski peptidi
BRPI1010661A2 (pt) peptídeo
EP2101804A4 (en) PROANGIOGENIC PEPTIDES
ATE547425T1 (de) Optimiertes dengue-virus-eintrittshemmendes peptid (dn81)
EP2280988A4 (en) ANGIOGENIC PEPTIDE
FI20070508A0 (fi) Peptidisubstraatti ja sen käyttö
DK2021364T3 (da) Forbedrede antimikrobielle peptider
ATE530564T1 (de) Peptid-komplement-konjugate
DK1968623T3 (da) Bacteriocin-inducer-peptider